<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1506222211
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2004
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DEXAFLOX OPHTHALMIC SUSPENSION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        OFLOXACIN,DEXAMETHASONE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        3,1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ophthalmic use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Eye drops, solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Dropper Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        14.95
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jamjoom Pharmaceuticals Factory Company" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 394]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            JAMJOOM PHARMACEUTICALS CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory  Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01CA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dexaflox&trade; is indicated for steroid-responsive<br />inflammatory ocular conditions for which a<br />corticosteroid is indicated and where bacterial<br />ocular infection or a risk of infection exists.<br />Dexaflox&trade; is prescribed for you if you have<br />corticosteroid responsive inflammatory condition of<br />the conjunctiva, cornea and anterior segment of the<br />eye where bacterial infection or a risk of bacterial<br />infection exists. Steroid-responsive inflammations<br />are those inflammatory disorders that will respond<br />to corticosteroid treatment.<br />It works by reducing the intensity of the acute<br />inflammatory response and killing the bacteria.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use Dexaflox&trade; if you are<br />Hypersensitive to any of its components please ask<br />your doctor.<br />Take special care with Dexaflox&trade;<br />- If you are hypersensitive to any other quinolone<br />antibiotic.<br />- If you are allergic to dexamethasone or any of the<br />other ingredients of this medicine.<br />- Long term use may result in a new bacterial<br />infection which does not respond to ofloxacin.<br />- If you have a defect or ulceration of the surface of<br />the eye.<br />- Dexaflox&trade; potentially increases sensitivity to<br />sunlight. You should avoid exposure to direct<br />sunlight or sun during use.<br />- If you are suffering from cardiac disorders.<br />- In case of bacterial eye infections (such as: acute<br />purulent bacterial infections), fungal infections,<br />viral diseases (for example: Herpes simplex,<br />vaccinia, varicella zoster), or amoebiasis.<br />- In case of tuberculosis.<br />- In cases of damaged cornea (such as: perforation<br />of the cornea), ulceration, lesions with incomplete<br />formation of the covering tissue.<br />- In cases of increased intraocular pressure caused<br />by glucocorticosteroid.<br />Children<br />Use of Dexaflox&trade; eye drops in children and<br />adolescents must be restricted. In children,<br />continuous, long term use of corticosteroid eye<br />drops should be avoided.<br />Using other medicines<br />Please tell your doctor or pharmacist if you are<br />taking or have recently taken any other medicines,<br />including medicines obtained without a<br />prescription.<br />Pregnant women and breast feeding women<br />Tell your doctor before you start using Dexaflox&trade;<br />if you are pregnant or if you are breast-feeding.<br />Your doctor can then decide whether you can use it.<br />Driving and using machines<br />Your sight may become blurred for a short time just<br />after using Dexaflox&trade;. You should not drive or use<br />machines until your sight is clear again.<br />Use with contact lenses<br />Dexaflox&trade; contains benzalkonium chloride which<br />may cause ocular irritation and discolor soft contact<br />lenses.<br />Generally wearing contact lenses is not<br />recommended in patients receiving treatment for an<br />eye infection.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use Dexaflox&trade; exactly as your doctor has<br />told you. Check with your doctor or pharmacist if<br />you are not sure.<br />The recommended dose is 1 drop in one or both<br />eyes, 4 to 6 times a day in the affected eye.<br />In severe cases, treatment may be started with 1<br />drop every hour at the start of the therapy but<br />dosage should be reduced to 1 drop every 4 hours<br />when a favourable response is observed. Do not<br />stop using the treatment abruptly. Gradual tapering<br />off is recommended in order to avoid a relapse. The<br />duration of treatment will generally vary from a few<br />days to a maximum of 14 days.<br />Use this much unless your doctor tells you to do<br />differently. Only use Dexaflox&trade; in both eyes if your<br />doctor told to you.<br />Only use Dexaflox&trade; as an eye drop.<br />Instructions for using eye drops<br />&bull; First wash your hands.<br />&bull; Shake the bottle well before use.<br />&bull; Remove the cap of the bottle.<br />&bull; Tilt your head back a little and pull the lower lid<br />of your eye downwards to form a pocket.<br />&bull; Hold the bottle upside down near to your eye.<br />&bull; Try not to touch your eye as you do this.<br />&bull; Apply enough pressure to release one drop into<br />your eye.<br />&bull; Close your eye for a minute or two, and press<br />gently on the side of your nose where the corner of<br />your eye meets your nose. This helps to stop the<br />drop from draining away and keeps it in your eye.<br />&bull; Repeat the process in your other eye if it also<br />needs treatment.<br />&bull; After using the bottle, reclose it.<br />How much to use:<br />If a drop misses your eye, try again.<br />To avoid eye injury and contamination, do not let<br />the tip of the dropper touch your eye or anything<br />else.<br />If you forget to use Dexaflox&trade;, use a single drop<br />as soon as you remember, and then go back to your<br />regular routine. Do not use a double dose to make<br />up for the one missed.<br />If you are using other eye drops, wait at least five<br />to ten minutes between putting in Dexaflox&trade; and<br />the other drops.<br />If, by accident, anyone drinks this medicine, contact<br />your doctor straight away.<br />Do not stop using Dexaflox&trade; until your doctor has<br />told you to.<br />If you have any further questions on the use of this<br />product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Dexaflox&trade; can cause side<br />effects, although not everybody gets them.<br />Occasionally this medicine may cause temporary<br />stinging, burning, redness or watering of the eyes.<br />In very rare cases, some patients with severe<br />damage to the clear layer at the front of the eye (the<br />cornea) have developed cloudy patches on the<br />cornea due to calcium build-up during treatment.<br />Topical corticosteroids should not be used for<br />longer than one week except under ophthalmic<br />supervision. You should consult your doctor if you<br />become aware of any changes in your eyesight.<br />It is possible that some of the solution may be<br />absorbed into the general circulation of the body<br />following administration to the eye. It is unlikely,<br />however, that this will have any unwanted effect on<br />the body because so little of the eye drop is<br />absorbed through the eye. The action of pressing on<br />the inner part of the eye when adding the drops will<br />also help to reduce this absorption even further.<br />If it does happen, it can cause hormone problems:<br />growth of extra body hair (particularly in women),<br />muscle weakness and wasting, purple stretch marks<br />on body skin, increased blood pressure, irregular or<br />missing periods, changes in the levels of protein<br />and calcium in your body, stunted growth in<br />children and teenagers and swelling and weight<br />gain of the body and face (called &lsquo;Cushing&rsquo;s<br />syndrome&rsquo;)<br />Serious side effects:<br />If you have one or more of the following side<br />effects, you may have had a serious allergic<br />reaction. Stop taking Dexaflox&trade; immediately and<br />contact your physician.<br />Allergic reactions:<br />&bull; Allergic reactions in the eye (including itchiness<br />of the eye and/or eyelid)<br />&bull; Inflammation of the skin due to allergy<br />(including: rash, itching or hives)<br />&bull; Severe sudden life-threatening allergic reaction<br />(Anaphylactic) presenting as swelling beneath the<br />skin that can occur in areas such as the face, lips or<br />other parts of the body, swelling of the mouth,<br />tongue or throat that can obstruct the airways which<br />may cause wheezing, difficulty swallowing,<br />breathing or shortness of breath<br />Common side effects (may affect up to 1 in 10<br />people)<br />&bull; Eye irritation &bull; Ocular discomfort<br />Side effects affecting the eye:<br />&bull; Visual disturbance<br />&bull; Tearing<br />&bull; Inflammation<br />&bull; Redness<br />&bull; Sensitivity to light<br />&bull; A feeling that something is in your eye<br />&bull; Eye swelling<br />&bull; Swelling around the eyes (including eyelid<br />swelling)<br />&bull; Eye pain<br />&bull; Dryness (mild stinging or burning)<br />Side effects affecting the body:<br />&bull; Dizziness<br />&bull; Nausea</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep out of the reach and sight of children.<br />&bull; Do not store above 30 OC.<br />&bull; Dexaflox&trade; eye drops are sterile when first<br />opened, it is important to keep the drops as clean as<br />possible during use.<br />&bull; Discard after 30 days of opening.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; The active ingredients are ofloxacin and<br />dexamethasone. Each ml contains:<br />ofloxacin 3.0 mg and dexamethasone 1.0 mg.<br />&bull; The other ingredients are benzalkonium chloride,<br />disodium edetate, hydroxypropyl methylcellulose,<br />sodium chloride, sodium hydroxide, sodium<br />sulphate anhydrous, sulphuric acid, tyloxapol and<br />water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                • Dexaflox™ eye drops is a slightly yellowish
suspension, free from visible contamination.
• Dexaflox™ eye drops suspension, 5 ml filled in
LDPE bottle.
Marketing Authorisation Holder and
Manufacturer
Jamjoom Pharmaceuticals Co.,
Jeddah, Saudi Arabia.
Tel: +966-12-6081111, Fax: +966-12-6081222.
Website: www.jamjoompharma.com
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Jamjoom Pharmaceuticals Co.,<br />Jeddah, Saudi Arabia.<br />Tel: +966-12-6081111, Fax: +966-12-6081222.<br />Website: www.jamjoompharma.com<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />- The National Pharmacovigilance and<br />Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222,<br />Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                12/2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>وصف لحالات الالتهابات العينية التي &trade; ديكسافلوكس<br />تستجيب للستيرويدات والتي يوصف لها كورتيكوستيرويد و<br />كذلك توجد عدوى بكتيرية في العين أو خطر الإصابة<br />بالعدوي.<br />هى عبارة عن مجموعة من الأدوية تستخدم &trade; ديكسافلوكس<br />لعلاج حالات التهابات العين التي تحدث بسبب العدوى<br />البكتيرية أو لمعالجة خطر الإصابة بالعدوى البكتيرية.<br />قطرة للعين لك إذا كنت تُعَاني من &trade; يتم وصف ديكسافلوكس<br />حالات التهابات الملتحمة والقرنية والجزء الأمامي من العين<br />والتي تستجيب للكورتيكوستيرويدات حيث تحدث بسبب<br />العدوى البكتيرية أو لمعالجة خطر الإصابة بالعدوى<br />البكتيرية. الالتهابات التي تستجيب للستيرويدات هي تلك<br />الاضطرابات الالتهابية التي من شأنها الاستجابة للعلاج<br />بالكورتيكوستيرويدات.<br />يعمل هذا الدواء عن طريق تقليل شدة استجابة الالتهاب الحاد<br />وقتل البكتيريا.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>قطرة للعين إذا &trade; لا تقم باستخدام ديكسافلوكس<br />كنت تعاني من حساسية تجاه أي مكون من المكونات الداخلة<br />في تركيب الدواء ويُرجى استشارة الطبيب المعالج لك.<br />قطرة للعين &trade; توخ حذرًا خاصًا عند استخدام ديكسافلوكس<br />في الحالات الآتية:<br />- إذا كنت شديد الحساسية تجاه أي مضاد حيوي آخر من<br />الكينولون.<br />- إذا كنت تعاني من حساسية من ديكساميثازون أو أي من<br />المكونات الأخرى لهذا الدواء.<br />- قد يؤدي الاستخدام طويل المدى إلى عدوى بكتيرية جديدة<br />لا تستجيب لأوفلوكساسين.<br />- إذا كان لديك عيب أو تقرح في سطح العين.<br />من حساسية ضوء &trade; - من المحتمل أن يزيد ديكسافلوكس<br />الشمس. يجب تجنب التعرض لأشعة الشمس المباشرة أو<br />الشمس أثناء الاستخدام.<br />- إذا كنت تعاني من اضطرابات قلبية.<br />- في حالة العدوى البكتيرية للعيون (مثل: العدوى البكتيرية<br />الصدرية الحادة) ، والالتهابات الفطرية ، والأمراض<br />الفيروسية (على سبيل المثال: الهربس البسيط ، اللقاحية ،<br />الحماق النطاقي) ، أو الأميبية.<br />- في حالة مرض السل.<br />- في حالات القرنية المتضررة (مثل: ثقب القرنية) ، التقرح ،<br />الآفات غير المكتملة لتشكيل الأنسجة المغطية.<br />- في حالات زيادة ضغط العين الناجمة عن<br />الجلوكوكورتيكوستيرويد.<br />قطرة للعين: &trade; استخدام أدوية أخرى مع ديكسافلوكس<br />يُرجى إبلاغ الطبيب المعالج لك أو الصيدلي الخاص بك إذا<br />كنت تستخدم أو استخدمت مؤخرًا أية أدوية أخرى، بما في<br />ذلك الأدوية التي حصلت عليها دون وصفة طبية.<br />السيدات الحوامل و المرضعات<br />إذا كنت &trade; أخبري طبيبك قبل البدء باستخدام ديكسافلوكس<br />حاملاً أو إذا كنت ترضعين طفلك. يستطيع طبيبك بعد ذلك أن<br />يقرر ما إذا كان بإمكانك استخدامه.<br />القيادة واستخدام الآلات<br />قد تصبح الرؤية مشوشة لفترة قصيرة فقط بعد استخدام<br />قطرة للعين. يجب عليك تجنب القيادة أو &trade; ديكسافلوكس<br />استخدام الآلات حتى تتضح الرؤية مرة أخرى.<br />استخدام القطرة مع العدسات اللاصقة<br />قطرة للعين على كلوريد البنزالكونيوم &trade; تحتوي ديكسافلوكس<br />الذي قد يسبب تهيُّج العينين ومن المعروف أنه يسبب تغير<br />لون العدسات اللاصقة اللينة.<br />لا يوصى بارتداء العدسات اللاصقة بوجه عام في المرضى<br />الذين يتم علاجهم من عدوى العين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>قطرة للعين وفقًا لتعليمات الطبيب &trade; استخدم دائمًا ديكسافلوكس<br />المعالج لك. يُرجى مراجعة الطبيب المعالج لك أو الصيدلي<br />الخاص بك إذا لم تكن متأكدًا من كيفية الاستخدام.<br />الجرعة الموصى بها هي قطرة واحدة في العين أو كلتا<br />العينين ، من ٤ إلى ٦ مرات في اليوم في العين المصابة.<br />في الحالات الشديدة ، قد يبدأ العلاج مع قطرة واحدة كل ساعة<br />في بداية العلاج ولكن يجب تخفيض الجرعة إلى قطرة واحدة<br />كل ٤ ساعات عند ملاحظة استجابة مواتية. لا تتوقف عن<br />استخدام العلاج فجأة. ينصح بالتناقص التدريجي من أجل<br />تجنب الانتكاس. تختلف مدة العلاج بشكل عام من بضعة أيام<br />إلى مدة أقصاها ۱٤ يومًا.<br />استخدم هذا القدر ما لم يخبرك طبيبك أن تفعله بشكل مختلف.<br />في كلتا العينين إذا أخبرك الطبيب &trade; استخدم فقط ديكسافلوكس<br />بذلك.<br />كقطرة للعين فقط. &trade; استخدم ديكسافلوكس<br />تعليمات لاستخدام قطرة العين:<br />&bull; اغسل يديك أولًا.<br />&bull; قم برَج الزجاجة جيدًا قبل الاستخدام.<br />&bull; انزع غطاء الزجاجة.<br />&bull; قم بإمالة رأسك قليلًا إلى الخلف، ثم اسحب جفن العين<br />السفلي إلى أسفل لتشكيل تجويف توضع القطرة بداخله.<br />&bull; امسك الزجاجة مقلوبة على مقربة من العين.<br />&bull; حاول ألا تلمس عينك وأنت تقوم بهذه الخطوات.<br />&bull; اضغط ضغطًا كافيًا لإخراج قطرة واحدة في العين.<br />&bull; أغلق عينيك لمدة دقيقة أو دقيقتين، ثم اضغط بلطف على<br />جانب الأنف حيث تلتقي زاوية العين مع الأنف. حيث يساعد<br />هذا الإجراء على وقف سيلان القطرة من موضعها ويبقيها في<br />العين.<br />&bull; كرر هذه الخطوات في العين الأخرى، إذا كانت هي<br />الأخرى تحتاج للعلاج.<br />&bull; أعد غلق الزجاجة بعد استخدامها.<br />ما هي الكمية التي يجب أن تُستخدَم:<br />حاول مرة أخرى إذا سقطت القطرة من العين.<br />لا تدع رأس القطارة أو أي شيء آخر يلمس العين، لتجنب<br />إيذاء العين وتلوثها.<br />قطرة للعين، فاستخدم &trade; إذا أغفلت استخدام ديكسافلوكس<br />قطرة واحدة بمجرد تذكرك لذلك الأمر، ثم استمر في استخدام<br />الجرعات المُعتادة.<br />لا تستخدم جرعة مضاعفة لتعويض الجرعة التي أغفلتها.<br />في حال استخدام قطرات عين أخرى، انتظر على الأقل من<br />قطرة للعين &trade; خمس إلى عشر دقائق بين استخدام ديكسافلوكس<br />وقطرات العين الأخرى.</p><p>اتصل بالطبيب المعالج لك على الفور إذا شرب أي شخص<br />هذا الدواء عن طريق الخطأ.<br />قطرة للعين حتى يخبرك &trade; لا تتوقف عن استخدام ديكسافلوكس<br />الطبيب المعالج لك بذلك.<br />استشر الطبيب المعالج لك أو الصيدلي الخاص بك إذا كانت<br />لديك أية أسئلة أخرى حول استخدام هذا المنتج.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>٤. الآثار الجانبية المُحتملة<br />قطرة للعين آثارًا &trade; مثل كافة الأدوية، فقد تُسبب ديكسافلوكس<br />جانبية، على الرغم من عدم حدوثها لجميع المرضى.<br />من حين لآخر قد يسبب هذا الدواء مؤقتا لسعة ، حرقان ،<br />احمرار أو تدمع العيون.<br />في حالات نادرة جدا ، بعض المرضى الذين يعانون من<br />ضرر شديد للطبقة الواضحة في مقدمة العين (القرنية) قد<br />تطور معهم بقعًا غائمة على القرنية بسبب تراكم الكالسيوم<br />أثناء العلاج.<br />لا ينبغي أن تستخدم الكورتيكوستيرويدات الموضعية لأكثر<br />من أسبوع واحد إلا تحت الإشراف الطبي علي العين. يجب<br />عليك استشارة طبيبك إذا كنت على علم بأي تغييرات في<br />بصرك.<br />من الممكن أن يتم امتصاص بعض المحاليل في الدورة<br />الدموية العامة للجسم بعد إستخدامها للعين. غير أنه من غير<br />المحتمل أن يكون لهذا أي تأثير غير مرغوب فيه على الجسم<br />لأن القليل جدا من قطرة العين يتم امتصاصه من خلال العين.<br />سيساعد عمل الضغط على الجزء الداخلي من العين عند<br />إضافة القطرات أيضًا على تقليل هذا الامتصاص إلى أبعد من<br />ذلك.<br />إذا حدث ذلك ، يمكن أن يسبب مشاكل هرمونية:<br />نمو شعر الجسم الزائد (خاصة عند النساء) ، ضعف<br />العضلات والهزال ، علامات التمدد الأرجواني على جلد<br />الجسم ، زيادة ضغط الدم ، دورات طمث غير منتظمة أو<br />مفقودة ، تغيرات في مستويات البروتين و الكالسيوم في<br />جسمك ، توقف النمو لدى الأطفال والمراهقين وتورم وزيادة<br />وزن الوجه والجسم (يسمى &quot;متلازمة كوشينغ&quot;)<br />آثار جانبية خطيرة:<br />إذا كان لديك واحد أو أكثر من الآثار الجانبية التالية ، فقد<br />يكون لديك رد فعل تحسسي خطير. توقف عن تناول<br />على الفور و اتصل بطبيبك. &trade; ديكسافلوكس<br />ردود الفعل التحسسية:<br />&bull; الحساسية في العين (بما في ذلك حكة العين و / أو الجفن)<br />&bull; التهاب الجلد بسبب الحساسية (بما في ذلك: الطفح الجلدي ،<br />الحكة أو الشري)<br />&bull; رد فعل تحسسية مهددة للحياة تظهر على شكل تورم تحت<br />الجلد يمكن أن يحدث في مناطق مثل الوجه ، الشفتين أو<br />أجزاء أخرى من الجسم ، تورم في الفم ، اللسان ، الحلق و<br />الذي يمكن أن يعوق المجاري الهوائية مما قد يسبب الصفير ،<br />صعوبة البلع و التنفس أو ضيق في التنفس.<br />الآثار الجانبية الشائعة ( قد تؤثر على ۱ من كل ۱۰<br />أشخاص)<br />&bull; تهيج العين &bull; عدم الراحة في العين<br />الآثار الجانبية التي تؤثر على العين:<br />&bull; اضطراب بصري &bull; تمزيق<br />&bull; التهاب &bull; احمرار<br />&bull; الحساسية للضوء<br />&bull; الشعور بأن شيئًا ما في عينك<br />&bull; تورم العين<br />&bull; تورم حول العينين (بما في ذلك تورم الجفن)<br />&bull; ألم في العين &bull; جفاف (لسع أو حرقان خفيف)<br />الآثار الجانبية التي تؤثر على الجسم:<br />&bull; دوخة &bull; غثيان</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull; يحفظ بعيداً عن متناول و مرأى الأطفال.<br />&bull; يحفظ في درجة حرارة لاتزيد عن ۳۰ درجة مئوية.<br />قطرة للعين تكون معقمة عند فتحها لأول &trade; &bull; ديكسافلوكس<br />مرة، من المهم أن تظل القطرات نظيفة بأكبر قدر ممكن خلال<br />الاستخدام.<br />&bull; لا يستعمل الدواء بعد ۳۰ يوما من تاريخ فتح الزجاجة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ما هي مكونات ديكسافلوكس<br />&bull; المواد الفعالة هي: أوفلوكساسين وديكساميثازون.<br />كل ۱ مل يحتوى على :<br />أوفلوكساسين ۳ ملغ و ديكساميثازون ۱ ملغ.<br />&bull; المكونات الأخرى: كلوريد البنزالكونيوم، ثنائي صوديوم<br />الإيديتات، هيدروكسي بروبيل ميثيل سيليولوز، كلوريد<br />الصوديوم، هيدروكسيد الصوديوم، كبريتات الصوديوم<br />اللامائية، حمض الكبريتيك، تيلوكسابول وماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>طرة للعين هي معلق مائل للصفرة خال من &trade; &bull; ديكسافلوكس<br />الملوثات المرئية.<br />قطرة للعين معلق, ٥ مل في قطارة من &trade; &bull; ديكسافلوكس<br />البولي إيثيلين منخفض الكثافة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة مصنع جمجوم للأدوية،<br />جدة، المملكة العربية السعودية.<br />،+۹٦٦-۱۲- الهاتف: ٦۰۸۱۱۱۱<br />+۹٦٦-۱۲- فاكس: ٦۰۸۱۲۲۲<br />www.jamjoompharma.com : الموقع الإلكتروني<br />للإبلاغ عن أي أثار جانبيه:<br />&bull; المملكة العربية السعودية:<br />- المركز الوطني للتيقظ و السلامة الدوائية<br />+۹٦٦-۱۱-۲۰٥- فاكس: ۷٦٦۲ o<br />للإتصال بالإدارة التنفيذية للتيقظ وإدارة الأزمات. o<br />+۹٦٦-۱۱- هاتف: ۲۰۳۸۲۲۲<br />۲۳٤۰-۲۳۳٤-۲۳٥٤-۲۳٥۳-۲۳٥٦- تحويلة: ۲۳۱۷<br />الهاتف المجاني: ۸۰۰۲٤۹۰۰۰۰ o<br />npc.drug@sfda.gov.sa : بريد إلكتروني o<br />www.sfda.gov.sa/npc : الموقع الالكتروني o<br />&bull; دول الخليج الأخرى:<br />- الرجاء الاتصال بالمؤسسات و الهيئات الوطنية في كل<br />دولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            12/2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dexaflox Ophthalmic Suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each ml of Dexaflox Ophthalmic Suspension
Contains: Ofloxacin 3.0 mg and Dexamethasone 1.0 mg
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Eye drops, solution
Clear, pale to light yellow-green solution, practically free from visible particles.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dexaflox Ophthalmic Suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial ocular infection or a risk of infection exists.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Adults (including the elderly)<br />The usual dose in adults, including the elderly, is 1 drop, 4 to 6 times daily.<br />In severe conditions, the treatment can be used more frequently at first (1 drop every hour), and then reduced to 1 drop every 4 hours as the eye inflammation subsides. Dexamethasone sodium phosphate dosage should be progressively reduced.<br />Paediatric population<br />Use of Dexaflox in children and adolescents must be restricted. No data on safety and efficacy are available for children aged less than 2 years. Currently available data are described in sections 4.8, 5.1 and 5.2 but no recommendation on a posology can be made. In children, long- term continuous corticosteroid therapy should be avoided due to possible adrenal suppression (see section 4.4).<br />Method of administration<br />Ocular use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ofloxacin
Contra-indicated in individuals who have shown hypersensitivity to ofloxacin, any of its excipients or any other quinolones.
Dexamethasone
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Use is contra-indicated in herpes simplex and other viral diseases of the cornea and conjunctiva, fungal disease, ocular tuberculosis, untreated purulent infections, patients with a history of acute epithelial herpes simplex keratitis or hypersensitivity to any component of the preparation.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ofloxacin<br />Safety and effectiveness in infants below the age of one year have not been established.<br />Serious and occasionally fatal hypersensitivity (anaphylactic/anaphylactoid) reactions, some following the first dose, have been reported in patients receiving systemic quinolones, including ofloxacin. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, angioedema (including laryngeal, pharyngeal or facial oedema), airway obstruction, dyspnoea, urticaria, and itching.<br />If an allergic reaction to Ofloxacin occurs, discontinue the drug. Use Ofloxacin with caution in patients who have exhibited sensitivities to other quinolones antibacterial agents.<br />When using Ofloxacin the risk of rhinopharyngeal passage which can contribute to the occurrence and the diffusion of bacterial resistance should be considered. As with other anti-infectives, prolonged use may result in overgrowth of non-susceptible organisms.If worsening infection occurs, or if clinical improvement is not noted within a reasonable period, discontinue use and institute alternative therapy.<br />Cardiac disorders<br />Caution should be taken when using fluoroquinolones, including Ofloxacin in patients with known risk factors for prolongation of the QT interval such as, for example:<br />- Congenital long QT syndrome<br />- Concomitant use of drugs that are known to prolong the QT interval (e.g. Class IA and III anti-arrhythmics, tricyclic antidepressants, macrolides, antipsychotics)<br />- Uncorrected electrolyte imbalance (e.g. hypokalaemia, hypomagnesaemia)<br />- Cardiac disease (e.g. heart failure, myocardial infarction, bradycardia)<br />Elderly patients and women may be more sensitive to QTc-prolonging medications. Therefore, caution should be taken when using fluoroquinolones, including Ofloxacin, in these populations.<br />Use Ofloxacin with caution in patients who have exhibited sensitivities to other quinolone antibacterial agents.<br />Data are very limited to establish efficacy and safety of Ofloxacin eye drops 0.3% in the treatment of conjunctivitis in neonates.<br />The use of Ofloxacin eye drops in neonates with ophthalmia neonatorum caused by Neisseria gonorrhoeae or Chlamydia trachomatis is not recommended as it has not been evaluated in such patients.<br />Use in elderly: No comparative data are available with topical dosing in elderly versus other age groups.<br />Clinical and non-clinical publications have reported the occurrence of corneal perforation in patients with pre-existing corneal epithelial defect or corneal ulcer, when treated with topical fluoroquinolone antibiotics. However, significant confounding factors were involved in many of these reports, including advanced age, presence of large ulcers, concomitant ocular conditions (e.g. severe dry eye), systemic inflammatory diseases (e.g. rheumatoid arthritis), and concomitant use of ocular steroids or non-steroidal anti-inflammatory drugs.</p><p>Nevertheless, it is necessary to advise caution regarding the risk of corneal perforation when using product to treat patients with corneal epithelial defects or corneal ulcers.<br />Corneal precipitates have been reported during treatment with topical ophthalmic Ofloxacin. However, a causal relationship has not been established.<br />Long-term, high-dose use of other fluoroquinolones in experimental animals has caused lenticular opacities. However, this effect has not been reported in human patients, nor has it been noted following topical ophthalmic treatment with Ofloxacin for up to six months in animal studies including studies in monkeys.<br />Ofloxacin contains the preservative benzalkonium chloride which may cause ocular irritation and discolour soft contact lenses.<br />Sun or UV-exposition should be avoided during use of Ofloxacin due to the potential for photosensitivity.<br />Use of contact lenses is not recommended in patients receiving treatment for an eye infection.<br />Dexamethasone<br />For ocular use only. Not for injection into the eye.<br />In those diseases causing thinning of the cornea or sclera, perforations have been known to occur with the use of topical corticosteroids.<br />Caution is also necessary when used in conjunction with antiviral therapy in the treatment of stromal keratitis or uveitis and use of periodic slit-lamp microscopy.<br />Corticosteroids may reduce resistance to and aid in the establishment of bacterial, viral and fungal infections and mask the clinical signs of infections, preventing recognition of ineffectiveness of the antibiotic. In such cases antibiotic therapy is mandatory. Fungal infection should be suspected in patients with persistent corneal ulceration who have been or are receiving these drugs, and corticosteroids therapy should be discontinued if fungal infection occurs.<br />This medicinal product contains phosphates which may lead to corneal deposits or corneal opacity when topically administered. It should be used with caution in patients presenting with compromised cornea and in instances where the patient is receiving polypharmacy with other phosphate-containing eye medications (see section 4.5).</p><p>Topical corticosteroids should not be used for longer than one week except under ophthalmic supervision. Prolonged use of topical ophthalmic corticosteroids may result in ocular hypertension and/or glaucoma, with damage to the optic nerve, reduced visual acuity, visual field defects and posterior subcapsular cataract formation. In patients receiving prolonged ophthalmic corticosteroid therapy, intraocular pressure and the lens should be checked routinely and frequently, particularly in patients with a history or presence of glaucoma. The dose of anti-glaucoma medication may need to be adjusted in these patients. Prolonged use may also increase the hazard of secondary ocular infections. Topical ophthalmic corticosteroids may slow corneal wound healing.<br />Cushing&#39;s syndrome and/or adrenal suppression associated with systemic absorption of ophthalmic dexamethasone may occur after intensive or long-term continuous therapy in predisposed patients, including children and patients treated with CYP3A4 inhibitors (including ritonavir and cobicistat). In these cases, treatment should be progressively discontinued.<br />Contact lenses should not be worn during treatment with corticosteroid eye drops due to increased risk of infection.<br />Systemic absorption may be reduced by compressing the lacrimal sac at the medial canthus for a minute during and following the instillation of the drops. (This blocks the passage of drops via the naso-lacrimal duct to the wide absorptive area of the nasal and pharyngeal mucosa. It is especially advisable in children.)<br />Paediatric population<br />In children, long-term, continuous corticosteroid therapy should be avoided due to possible adrenal suppression.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ofloxacin No interaction studies have been performed.<br />It has been shown that the systemic administration of some quinolones inhibits the metabolic clearance of caffeine and theophylline. Drug interaction studies conducted with systemic ofloxacin have demonstrated that metabolic clearance of caffeine and theophylline are not significantly affected by ofloxacin.<br />Although there have been reports of an increased prevalence of CNS toxicity with systemic dosing of fluoroquinolones when used concomitantly with systemic nonsteroidal anti-inflammatory drugs (NSAIDs), this has not been reported with the concomitant systemic use of NSAIDs and ofloxacin.<br />Ofloxacin, like other fluoroquinolones, should be used with caution in patients receiving drugs known to prolong the QT interval (e.g. Class IA and III anti-arrhythmics, tricyclic antidepressants, macrolides, antipsychotics).<br />Dexamethasone<br />The risk of increased intraocular pressure associated with prolonged corticosteroid therapy may be more likely to occur with concomitant use of anticholinergics, especially atropine and related compounds, in patients predisposed to acute angle closure.<br />The risk of corneal deposits or corneal opacity may be more likely to occur in patients presenting with compromised cornea and receiving polypharmacy with other phosphate-containing eye medications.<br />The therapeutic efficacy of dexamethasone may be reduced by phenytoin, phenobarbitone, ephedrine and rifampicin.<br />Glucocorticoids may increase the need for salicylates as plasma salicylate clearance is increased.<br />CYP3A4 inhibitors (including ritanovir and cobicistat) may decrease dexamethasone clearance resulting in increased effects and adrenal suppression/Cushing&#39;s syndrome. The combination should be avoided unless the benefit outweighs the increased risk of systemic corticosteroid side-effects, in which case patients should be monitored for systemic corticosteroid effects.<br />If more than one topical ophthalmic medicinal product is being used, the medicines must be administered at least 5 minutes apart. Eye ointments should be administered last.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ofloxacin Use in pregnancy: There have been no adequate and well-controlled studies performed in pregnant women. Since systemic quinolones have been shown to cause arthropathy in immature animals, it is recommended that Ofloxacin not be used in pregnant women.<br />Use during lactation: Because ofloxacin and other quinolones taken systemically are excreted in breast milk, and there is potential for harm to nursing infants, a decision should be made whether to temporarily discontinue nursing or not to administer the drug, taking into account the importance of the drug to the mother<br />Dexamethasone<br />Pregnancy<br />There are no or limited amount of data from the use of dexamethasone eye drops in pregnant women. Studies in animals have shown that topically applied steroids can be absorbed systemically and can cause abnormalities of fetal development in pregnant animals. Although the relevance of these findings to human beings has not been established, the use of Dexamethasone during pregnancy should be avoided.<br />Breastfeeding<br />Systemically administered corticosteroids appear in human milk in quantities that could affect the child being breastfed. However, when instilled topically, systemic exposure is low. It is unknown whether dexamethasone is excreted in human milk. A risk to the suckling child cannot be excluded. A decision must be made whether to discontinue breastfeeding or to discontinue/abstain from dexamethasone therapy taking into account the benefit of breastfeeding for the child and the benefit of therapy for the woman.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ofloxacin No studies on the effects on the ability to drive and use machines have been performed. Transient blurring of vision may occur on instillation of eye drops. Do not drive or operate hazardous machinery unless vision is clear.<br />Dexamethasone<br />Have no or negligible influence on the ability to drive and use machines; however, instillation of eye drops may cause transient blurring of vision. Warn patients not to drive or operate hazardous machinery until vision is clear.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ofloxacin<br />General</p><p>Serious reactions after use of systemic ofloxacin are rare and most symptoms are reversible. Since a small amount of ofloxacin is systemically absorbed after topical administration, side-effects reported with systemic use could possibly occur.<br />Frequency categories: Very common (&ge;1/10); Common (&ge;1/100 to &lt;1/10); Uncommon (&ge;1/1,000 to &lt;1/100); Rare (&ge;1/10,000 to &lt;1/1,000); Very rare (&lt;1/10,000) and not known (cannot be estimated from the available data):<br />Immune System Disorders<br />Not Known: Hypersensitivity reaction including signs or symptoms of Eye allergy (such as Eye pruritus and Eyelid pruritus) and anaphylactic reactions (such as angioedema, dyspnea, anaphylactic shock, oropharyngeal swelling, facial edema and tongue swollen)<br />Nervous System Disorders<br />Not known: Dizziness<br />Eye Disorders<br />Common: Eye irritation; Ocular discomfort<br />Not known: Keratitis; Conjunctivitis; Vision blurred; Photophobia; Eye edema; Foreign body sensation in eyes; Lacrimation increased; Dry eye; Eye pain; Ocular hyperaemia; Periorbital edema (including eyelid edema)<br />Cardiac disorders<br />Not known: ventricular arrhythmia and torsades de pointes (reported predominantly in patients with risk factors for QT prolongation); ECG QT prolonged. Gastrointestinal Disorders<br />Not known: Nausea<br />Skin and Subcutaneous Tissue Disorders<br />Not Known: Stevens-Johnson syndrome; Toxic epidermal necrolysis<br />Dexamethasone<br />The following undesirable effects are classified according to the following convention: very common (1/10), common (1/100 to &lt;1/10), uncommon (1/1,000 to &lt;1/100), rare (1/10,000 to &lt;1/1000), very rare (&lt;1/10,000), or not known (cannot be estimated from the available data).</p><p>Within each frequency grouping, undesirable effects are presented in decreasing order of seriousness.<br />Endocrine disorders<br />- Not known (cannot be estimated from the available data): Cushing&#39;s syndrome, adrenal suppression.<br />Ocular disorders:<br />- Very common (&gt;1/10): intraocular pressure increased (after 2 weeks of treatment).<br />- Common (&gt;1/100, &lt;1/10): ocular discomfort after instillation, irritation, burning, eye pruritus and blurred vision. These symptoms are mild and transient with no consequences.<br />- Uncommon (&gt;1/1,000, &lt;1/100): signs and symptoms of allergic or hypersensitive reactions can occur. The following corticoid specific undesirable effects can occur: delay in healing, risk of posterior subcapsular cataract formation, opportunist infections and glaucoma.<br />- Very rare (&lt;1/10,000, including isolated reports): conjunctivitis, eyelid oedema, corticoid-induced uveitis, keratitis, corneal thinning, corneal oedema and ulcerations. Cases of corneal calcification have been reported in association with the use of phosphate containing eye drops in some patients with significantly damaged corneas. Due to the steroid component, in diseases causing thinning of the cornea or sclera, there is a higher risk for perforation especially after topical long treatments.<br />General disorders and administration site conditions:<br />- Uncommon (&gt;1/1,000, &lt;1/100): after long treatment posology, systemic absorption can occur with an inhibition of the adrenal function<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222,<br />Exts: 2317-2356-2353-2354-2334-2340.<br />Toll free phone: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States: &minus; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ofloxacin<br />In the event of overdose, symptomatic treatment should be implemented. ECG monitoring should be undertaken, because of the possibility of QT interval prolongation.<br />Dexamethasone<br />Excess Dexamethasone Eye Drops may be wiped away with a clean tissue.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ofloxacin<br />Pharmacotherapeutic group: Ophthalmologicals, anti-infectives, fluoroquinolones<br />ATC code: S01AE01.<br />Ofloxacin is a synthetic fluorinated 4-quinolone antibacterial agent with activity against a broad spectrum of Gram negative and to a lesser degree Gram positive organisms.<br />Ofloxacin has been shown to be active against most strains of the following organisms both in vitro and clinically in ophthalmic infections. Clinical trial evidence of the efficacy of Ofloxacin against S. pneumoniae was based on a limited number of isolates.<br />Gram-negative bacteria: Acinetobacter calcoaceticus var. anitratum, and A. calcoaceticus var. iwoffi; Enterobacter Sp. including E. cloacae; Haemophilis Sp, including H. influenza and H. aegyptius; Klebsiella Sp., including K. Pneumoniae; Moraxella Sp., Morganella morganii; Proteus Sp., including P. Mirabilis; Pseudomonas Sp.; including P. Aeruginosa, P. cepacia, and P. fluoroscens; and Serratia Sp., including S. marcescens.<br />Gram-positive bacteria: Bacillus Sp.; Corynebacterium Sp.; Micrococcus Sp.; Staphylococcus Sp., including S. aureus and S. epidermidis; Streptococcus Sp., including S. Pneumoniae (see above), S. viridans and Beta-haemolytic.<br />The primary mechanisms of action is through inhibition of bacterial DNA gyrase, the enzyme responsible for maintaining the structure of DNA.<br />Ofloxacin is not subject to degradation by beta-lactamase enzymes nor is it modified by enzymes such as aminoglycoside adenylases or phosphorylases, or chloramphenicol acetyltransferase.</p><p>Dexamethasone<br />Pharmacotherapeutic group: Corticosteroids, plain, ATC code: S01 BA01<br />Dexamethasone is a highly potent and long-acting glucocorticoid. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid.<br />The actions of corticosteroids are mediated by the binding of the corticosteroid molecules to receptor molecules located within sensitive cells. Corticosteroid receptors are present in human trabecular meshwork cells and in rabbit iris ciliary body tissue.<br />Corticosteroids will inhibit phospholipase A2 thereby preventing the generation of substances which mediate inflammation, for example, prostaglandins. Corticosteroids also produce a marked, though transient, lymphocytopaenia. This depletion is due to redistribution of the cells, the T lymphocytes being affected to a greater degree than the B lymphocytes. Lymphokine production is reduced, as is the sensitivity of macrophages to activation by lymphokines. Corticosteroids also retard epithelial regeneration, diminish post-inflammatory neo- vascularisation and reduce towards normal levels the excessive permeability of inflamed capillaries.<br />The actions of corticosteroids described above are exhibited by dexamethasone and they all contribute to its anti-inflammatory effect.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ofloxacin<br />After ophthalmic instillation, ofloxacin is well maintained in the tear-film.<br />In a healthy volunteer study, mean tear film concentrations of ofloxacin measured four hours after topical dosing (9.2 &mu;g/g) were higher than the 2&mu;g/ml minimum concentration of ofloxacin necessary to inhibit 90% of most ocular bacterial strains (MIC90) in-vitro.<br />Maximum serum ofloxacin concentrations after ten days of topical dosing were about 1000 times lower than those reported after standard oral doses of ofloxacin, and no systemic side-effects attributable to topical ofloxacin were observed.</p><p>Dexamethasone<br />Absorption<br />When given topically to the eye, dexamethasone is absorbed into the aqueous humour, cornea, iris, choroid, ciliary body and retina. Systemic absorption occurs but may be significant only at higher dosages or in extended paediatric therapy. Up to 90% of dexamethasone is absorbed when given by mouth; peak plasma levels are reached between 1 and 2 hours after ingestion and show wide individual variations.<br />Distribution<br />Tissue distribution studies in animals show a high uptake of dexamethasone by the liver, kidney and adrenal glands; a volume of distribution has been quoted as 0.58 l/kg. In man, over 60% of circulating steroids are excreted in the urine within 24 hours, largely as unconjugated steroid.<br />Biotransformation<br />Dexamethasone sodium phosphate is rapidly converted to dexamethasone within the circulation. Up to 77% of dexamethasone is bound to plasma proteins, mainly albumin. This percentage, unlike cortisol, remains practically unchanged with increasing steroid concentrations. The mean plasma half-life of dexamethasone is 3.6 &plusmn; 0.9h.<br />Elimination<br />Dexamethasone also appears to be cleared more rapidly from the circulation of the foetus and neonate than in the mother; plasma dexamethasone levels in the foetus and the mother have been found in the ratio of 0.32:1.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ofloxacin There are no toxicological safety issues with this product in man as the level of systemic absorption from topical ocular administration of ofloxacin is minimal.<br />Animal studies in the dog have found cases of arthropathy in weight bearing joints of juvenile animals after high oral doses of certain quinolones. However, these findings have not been seen in clinical studies and their relevance to man is unknown</p><p>&nbsp;</p><p>Dexamethasone<br />Repeat dose topical ocular safety studies with dexamethasone in rabbits have shown systemic corticosteroid effects. Such effects are considered to be unlikely when dexamethasone eye drops are used as recommended.<br />Dexamethasone was clastogenic in the in vitro human lymphocyte assay and in vivo in the mouse micronucleus assay at doses in excess of those obtained following topical application. Conventional carcinogenicity studies with dexamethasone have not been performed.<br />Dexamethasone has been found to be teratogenic in animal models. Dexamethasone induced abnormalities of fetal development including cleft palate, intra-uterine growth retardation and effects on brain growth and development.<br />There are no other preclinical data of relevance to the prescriber which are additional to that included in other sections of the SPC.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Benzalkonium chloride<br />Disodium edetate<br />Hydroxypropyl methylcellulose<br />Sodium chloride<br />Sodium hydroxide<br />Sodium sulphate anhydrous<br />Sulphuric acid<br />Tyloxapol<br />Water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known. In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years, unopened.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Keep out of sight and reach of children.<br />Do not store above 30&deg;C.</p><p>Discard after 30 days of opening</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5 ml LDPE Opaque bottles</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not Applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jamjoom Pharmaceuticals Company Plot No. ME 1:3, Phase V, Industrial City, Jeddah
Postal address: P.O. Box 6267 Jeddah 21442, Saudi Arabia.
Tel: 00966-12-6081111
Fax: 00966-12-6081222
E-mail: jpharma@jamjoompharma.com
Website: www.jamjoompharma.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                08/2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>